Project Grant S10OD038230
- The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $255,500 Project Grant (CFDA 93.351) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a new digital multi-isotope autoradiography system. This advanced imaging equipment will be housed at the Institute for Innovation in Imaging at MGH and will provide highly sensitive, real-time analysis of isotope distribution in tissue samples. The award,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,485,000 Project Grant award from the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The award period runs from September 1, 2025 to August 31, 2028. The grant supports research focused on the discovery and characterization of programmable biological systems, particularly new RNA-guided functions found in...
- This $480,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will enable the Medical University of South Carolina (MUSC) to acquire a high-performance computing (HPC) cluster with extensive data storage and graphics co-processor (GCP) capabilities. This HPC infrastructure will support the integration of MUSC's expanding institutional data resources, including electronic health records, clinical...
- The U.S. National Institutes of Health (NIH), through its Office of Research Infrastructure Programs (ORIP), awarded a Project Grant under the Research Infrastructure Programs (CFDA 93.351) to the Fred Hutchinson Cancer Center in Seattle, Washington. The $2,000,000 grant, with a performance period from July 15, 2025 to July 14, 2026, will fund the replacement of the center's aging high-performance computing (HPC) cluster. The new 130-node, 7,799-core, 192 TB RAM HPC system with 1,753,088 CUDA...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,180,294 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to enhance precision oncology for underserved breast cancer patients through deep learning-aided histopathology analysis. The 3-year project, running from September 1, 2025 to August 31, 2028, aims to develop innovative diagnostic tools and therapeutic approaches...
- The National Science Foundation Division of Information and Intelligent Systems awarded a $999,710 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital, for research titled "COLLABORATIVE RESEARCH: NCS-FR: UNDERSTANDING THE NEUROPEPTIDE MODULATION OF BRAIN CIRCUITS BY ADVANCED NANOMATERIALS AND IMAGING." The award period is from September 1, 2021 to August 31, 2025. The grant supports research under the Computer and Information Science and...
- This federal Project Grant award, valued at $453,750.00 and effective September 1, 2025, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports a research program led by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to advance the understanding of perioperative neurocognitive disorders (PND) and their association with disruptions in...
- The Virginia Commonwealth University (VCU) received a $749,998 Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) to replace and expand the university's High Performance Research Computing (HPRC) cluster for biomedical research. The new state-of-the-art computing cluster will: 1) renew and expand CPU computing and memory capacity, 2) add GPU computing, 3) renew and expand the shared storage system, and 4) upgrade network...
- This Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will provide $252,500 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a "Versatile High-Throughput Alinity CI Assay Platform" to support multiple laboratory animal users. The new assay platform will replace MGH's existing end-of-life Architect platform, which has been essential for conducting...
- The University of Pittsburgh was awarded a $747,410 Project Grant from the Trans-NIH Research Support program (CFDA 93.310) by the U.S. Department of Health and Human Services National Institutes of Health, with a performance period of May 15, 2025 to May 14, 2026. The funds will be used to purchase a Dell PowerEdge XE9680 8X H100 GPU server with NV-Link, which will be housed at the university's Center for Biologic Imaging (CBI). The CBI serves NIH-supported researchers across the university and...
The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP), under the Research Infrastructure Programs (CFDA 93.351), awarded a $1,990,349 project grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to build and support a High-Performance Computing (HPC) cluster for computational pathology research. The project aims to address the growing need for enhanced data processing and analysis capabilities to support genomics, digital imaging, and spatial biology research at MGH. The HPC cluster will provide 10 CPU nodes, 7 petabytes of storage, 5 H100 GPU nodes, and advanced networking infrastructure to enable AI-driven data interpretation and accelerate pathology research. The award has a performance period from August 1, 2025, to July 31, 2026, and will be supported by in-kind contributions from MGH's digital and pathology leadership.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.0m | 7/30/25 |